This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Use of a Restrictive Fluid Regimen With Hypertonic Saline for Patients Undergoing Pancreaticoduodenectomy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2015 by Thomas Jefferson University.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
Thomas Jefferson University Identifier:
First received: August 31, 2011
Last updated: March 17, 2015
Last verified: March 2015
The Whipple operation is a complex surgical procedure involving the removal of the head of the pancreas, bile duct, and a portion of the intestine (duodenum) that is performed for patients who have cancer or some other condition affecting this region of the body. The Whipple operation is associated with a significant complication rate. Previous studies have shown that in a broad range of surgical procedures, using a reduced amount of intravenous fluids along with a special type of fluid called hypertonic saline during and after the procedure can lower complication rates associated with the heart and lungs during recovery from surgery. The purpose of this study is to determine if using a reduced amount of intravenous fluids as well as hypertonic saline (a salt concentrated form of intravenous fluids) during the Whipple operation and in the immediate period after surgery can reduce complications.

Condition Intervention Phase
Pancreaticoduodenectomy Drug: 3% NaCl Solution Drug: Lactated Ringers Solution Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Prospective Randomized Controlled Trial on the Use of a Restrictive Fluid Regimen With Hypertonic Saline for Patients Undergoing Pancreaticoduodenectomy

Resource links provided by NLM:

Further study details as provided by Thomas Jefferson University:

Primary Outcome Measures:
  • Anastomotic Leak [ Time Frame: 30 days ]
    Leak or defect of gastrointestinal anastomosis including but not limited to pancreaticojejunostomy

  • Delayed Gastric Emptying [ Time Frame: 30 days ]
    Rate of delayed gastric emptying post procedure, prolonged initiation of enteral feeding

  • Myocardial Infarction [ Time Frame: 30 days ]
  • Pneumonia [ Time Frame: 30 days ]
  • Wound Infection [ Time Frame: 30 days ]

Estimated Enrollment: 264
Study Start Date: May 2011
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 3% saline
Patients will received 3% saline in conjunction with lactated ringers solution intra and post operatively for a net reduction in total fluid administration
Drug: 3% NaCl Solution
1cc/kg/hr of 3%NaCl + 9cc/kg/hr of lactated ringers solution
Active Comparator: Lactated Ringers
15cc/kg/hr of lactated ringers solution intraoperatively
Drug: Lactated Ringers Solution
15cc/kg/hr for intraoperative fluids


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Physiologic suitability for major abdominal surgery
  • Aged 18 years and older
  • Written informed consent
  • Ability to understand and comply with study guidelines
  • Ability to obtain a central venous line

Exclusion Criteria:

  • Metabolic acidosis
  • Active Sepsis or Bacteremia
  • Chronic renal insufficiency
  • Hyponatremia (serum sodium <130)
  • Hypernatremia (serum sodium >150)
  • Pregnancy
  • Sickle cell anemia
  • Pediatric patients
  • BMI>40
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01428050

Contact: Harish Lavu, MD 215-955-9402

United States, Pennsylvania
Thomas Jefferson University Hospital Recruiting
Philadelphia, Pennsylvania, United States, 19107
Contact: Harish Lavu, MD    215-955-9402   
Sponsors and Collaborators
Thomas Jefferson University
Principal Investigator: Harish Lavu, MD Thomas Jefferson University
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Thomas Jefferson University Identifier: NCT01428050     History of Changes
Other Study ID Numbers: Jefferson Hypertonic
Study First Received: August 31, 2011
Last Updated: March 17, 2015

Keywords provided by Thomas Jefferson University:
hypertonic saline
fluid restriction
resuscitation strategy

Additional relevant MeSH terms:
Pharmaceutical Solutions processed this record on September 21, 2017